Single-Use Bioprocess Systems Market forecasted to surge ahead at a CAGR of 14.4% to reach US$ 22.2 Bn by the end of 2032

The single-use bioprocess system market is a rapidly growing segment of the biopharmaceutical industry. This market has been driven by several factors, including the increasing demand for biologics, the need for cost-effective manufacturing processes, and the desire for greater flexibility in biomanufacturing. Single-use bioprocess systems are gaining popularity due to their convenience and ease of use, especially in research and development and small-scale biomanufacturing. The single-use bioprocess system market is expected to continue to grow in the coming years as more biopharmaceutical companies adopt this technology.

The global single-use bioprocess systems market recorded a CAGR of 11.9% in the last six years from 2015 to 2021. Worldwide revenue from single-use bioprocess systems was US$ 5 Bn in 2021, with the market forecasted to surge ahead at a CAGR of 14.4% to reach a valuation of US$ 22.2 Bn by the end of 2032.

Need More Insights on Competitor Analysis of the Single Use Bioprocess System Market, Request for Sample@ https://www.persistencemarketresearch.com/samples/12142

The single-use bioprocess system market can be segmented based on product type, application, and end-users. The product type segment includes bags, filters, bioreactors, mixers, and others. The application segment includes cell culture, fermentation, filtration, purification, and others. The end-user segment includes biopharmaceutical companies, CROs, and academic and research institutions. The bags segment is the largest segment of the single-use bioprocess system market due to the wide range of applications and the ease of use.

Companies

Thermo Fisher Scientific Inc.
Sartorius Stedim Biotech
Danaher Corporation
Merck KGaA
Corning
Avantor
CESCO Bioengineering Co. Ltd.
PBS Biotech, Inc.
Distek, Inc.
Eppendorf AG
Celltainer Biotech B.V.
Getinge (Applikon Biotechnology)
Cellexus Ltd.
Parker Hannifin Corp
Mettler-Toledo International, Inc.

If You Want To Know The Business Opportunity/Market Value, Purchase The Premium Insight @ https://www.persistencemarketresearch.com/checkout/12142

One of the main advantages of single-use bioprocess systems is that they eliminate the need for cleaning and sterilization, which reduces the risk of cross-contamination and allows for faster turnaround times. Single-use bioprocess systems also reduce capital costs by eliminating the need for large, expensive equipment and infrastructure. This makes them particularly attractive to small biotech startups and contract manufacturing organizations (CMOs), who may not have the resources to invest in traditional stainless-steel bioreactors.

The single-use bioprocess system market is also being driven by the increasing demand for personalized medicine and the need for flexible manufacturing processes. Single-use bioprocess systems allow for greater flexibility in manufacturing, as they can be easily adapted to different cell lines and production processes. This is particularly important in the development of personalized medicines, where small batches of drugs are manufactured for specific patients.

Competitive Landscape

To strengthen their market presence and expand their product lines in the global market, leading manufacturers are focussing on various market strategies such as mergers and acquisitions, expansion of their production facilities, and collaborations with various other companies to boost their sales of single-use bioprocess systems.

For instance:

Thermo Fisher Scientific Inc. launched the Thermo Scientific DynaSpin single-use centrifuge system on September 28, 2022, at the BioProcess International Annual Conference in Boston, Massachusetts, to provide the finest single-use option for mass cell culture harvesting.
A contract extension with the U.S. Departments of Defence and Health & Human Services was announced by Corning on March 26, 2021.
To advance its Vertical-Wheel single-use bioprocessing technology and cater to the need for cell treatment, PBS Biotech, a producer of single-use bioreactors, signed a private investment round with BroadOak Capital Partners for US$ 10 million.

If you want to Purchase Specific Insights by Segment/Region/Competitor, Request For Customization @ https://www.persistencemarketresearch.com/request-customization/12142

Single-Use Bioprocess Systems Industry Research Segmentation

By Component:

Bioreactors
Cell Culture Bioreactors
Fermentation Bioreactors
Mixers
Bioprocess Containers
Transfer and Storage Bags
Sampling Systems
Filtration Systems
Chromatography Columns
Probes & Sensors
Tubing Assemblies
Connectors & Clamps
Filling Systems

By Application:

Research & Development (R&D)
GMP and Commercial Production

By End User:

Biopharmaceutical Companies
Contract Research Organizations
Contract Manufacturing Organizations
Research Institutes

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

Top Market Research Reports:

Single Domain Antibody Platforms Market: https://www.persistencemarketresearch.com/market-research/single-domain-antibody-platforms-market.asp

Single-use Bronchoscopes Market: https://www.persistencemarketresearch.com/market-research/single-use-bronchoscopes-market.asp

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.